BIOMAT Database Logo BIOMAT Database Logo

Effect of intravenous enkephalin administration on kallikrein-kinin system in experimental hemorrhagic shock. Evidence for activation of kallikrein-kinin system by naloxone. 1988

J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
Institute of Pathological Biochemistry, Medical Academy, Carl Gustav Carus, Dresden, GDR.

The effects of enkephalin derivates with different opioid receptor subtype specificity and naloxone on cardiovascular responses and kallikrein-kinin system (KKS) were studied in anesthetized rats exposed to 30% hemorrhage. Administration of a mu-receptor agonist (DAGO) in early hemorrhage improved mean arterial blood pressure (MAP) responses to hemorrhage. This effect could be abolished by naloxone pretreatment. Moreover, a delayed MAP recovery after hemorrhage could be observed. Treatment with a delta-agonist (DADL) resulted in transient depression of MAP and heart rate (HR). Hemorrhage by itself caused only a slight activation of KKS as indicated by decreased plasma kallikreinogen concentration and reduced kallikrein inhibitor capacity after 20% blood loss. Enkephalin administration did not exert significant effects on KKS. Naloxone pretreatment, in contrast, induced prehemorrhagic activation of KKS, which was potentiated by subsequent hemorrhage. Naloxone-induced activation of KKS could be confirmed by an in vitro study. Taken together these results suggest that the KKS is not involved in MAP and HR responses to enkephalin administration during hemorrhage, whereas it might be implicated in naloxone-induced delayed posthemorrhagic MAP recovery.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004743 Enkephalin, Leucine One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN. Leucine Enkephalin,5-Leucine Enkephalin,Leu(5)-Enkephalin,Leu-Enkephalin,5 Leucine Enkephalin,Enkephalin, 5-Leucine,Leu Enkephalin
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages

Related Publications

J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
Evidence for the activation of the kallikrein-kinin system in experimental asbestosis.
April 1984, Research communications in chemical pathology and pharmacology,
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
Kallikrein-kinin system activation in streptococcal toxic shock syndrome.
June 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
[Modification of the energy status of the liver in experimental hemorrhagic shock by intravenous enkephalin administration].
January 1988, Zeitschrift fur medizinische Laboratoriumsdiagnostik,
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
[Activation of the kallikrein-kinin system by endotoxin in the experimental shock model of the rat].
January 1985, Zeitschrift fur medizinische Laboratoriumsdiagnostik,
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
[Activation of the kallikrein-kinin system by intravenous administration of ionic and non-ionic radiographic contrast media].
July 1988, Deutsche medizinische Wochenschrift (1946),
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
[The kallikrein-kinin system and shock].
April 1982, Zeitschrift fur medizinische Laboratoriumsdiagnostik,
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
[Activation of the kallikrein-kinin system by clonidine].
November 1984, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
Changes of the kallikrein-kinin system in acute phase of hemorrhagic and septic shock.
November 1989, Nihon geka hokan. Archiv fur japanische Chirurgie,
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
[Response of kinin-kallikrein system in septic shock].
January 1975, Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan,
J Grässler, and H Kühne, and V D Slepuschkin, and G K Zoloev, and D W Scheuch
[The effect of agonists and antagonists of opiate receptors on the activity of the kallikrein-kinin system in hemorrhagic shock].
January 1992, Anesteziologiia i reanimatologiia,
Copied contents to your clipboard!